首页|期刊导航|检验医学与临床|脑小血管病患者血清LRG1、HDAC3、ZO-1水平与认知功能障碍的关系

脑小血管病患者血清LRG1、HDAC3、ZO-1水平与认知功能障碍的关系OA

Relationship between serum LRG1,HDAC3 and ZO-1 levels and cognitive impairment in patients with cerebral small vessel disease

中文摘要英文摘要

目的 探讨脑小血管病(CSVD)患者血清富亮氨酸α-2糖蛋白-1(LRG1)、组蛋白去乙酰化酶3(HDAC3)、闭锁小带蛋白1(ZO-1)水平与认知障碍(CI)的关系.方法 选取2023年11月至2024年11月该院收治的90例CSVD患者作为CSVD组,依据蒙特利尔认知评估量表评分结果将其分为功能障碍组(n=41)和功能正常组(n=49).另选择同期在该院体检的90例健康体检者作为对照组.采用酶联免疫吸附试验(ELISA)检测血清LRG1、HDAC3、ZO-1水平.采用多因素Logistic回归分析影响CSVD患者发生CI的因素.绘制受试者工作特征(ROC)曲线分析血清LRG1、HDAC3、ZO-1对CSVD患者发生CI的诊断价值.结果 与对照组相比,CSVD组血清LRG1、HDAC3水平显著升高(P<0.05),血清ZO-1水平显著降低(P<0.05);与功能正常组比较,功能障碍组血清甘油三酯、LRG1、HDAC3水平显著升高(P<0.05),血清ZO-1水平显著降低(P<0.05).多因素Logistic回归分析结果显示,血清LRG1、HDAC3水平升高是影响CSVD患者发生CI的独立危险因素(P<0.05),血清ZO-1水平升高是影响CSVD患者发生CI的独立保护因素(P<0.05).ROC曲线分析结果显示,血清LRG1、HDAC3、ZO-1单独诊断CSVD患者发生CI的曲线下面积(AUC)分别为0.818、0.808、0.827,三者联合诊断的 AUC为0.943,大于各指标单独诊断的 AUC(ZLRG1-三者联合=2.779、ZHDAC3-三者联合=3.068、ZZO-1-三者联合=2.480,均P<0.05).结论 CSVD患者血清LRG1、HDAC3水平上调,血清ZO-1水平下调,三者均是CSVD患者发生CI的影响因素,且三者联合检测对CI有较高的诊断价值.

Objective To investigate the relationship between serum leucine rich alpha-2 glycoprotein-1(LRG1),histone deacetylase 3(HDAC3),zonula occluden-1(ZO-1)levels and cognitive impairment(CI)in patients with cerebral small vessel disease(CSVD).Methods A total of 90 patients with CSVD admitted to the hospital from November 2023 to November 2024 were enrolled in the CSVD group.According to the scores of the Montreal Cognitive Assessment,they were divided into functional impairment group(n=41)and normal function group(n=49).Additionally,90 healthy individuals who underwent physical examinations at the hospital during the same period were selected as control group.Enzyme-linked immunosorbent assay(ELISA)method was used to detect serum LRG1,HDAC3 and ZO-1 levels.Multivariate Logistic regression analysis was used to identify factors influencing the occurrence of CI in patients with CSVD.Receiver operat-ing characteristic(ROC)curves were performed to discuss the diagnostic value of serum LRG1,HDAC3 and ZO-1 for CI in patients with CSVD.Results Compared with the control group,the serum LRG1 and HDAC3 levels in the CSVD group were higher(P<0.05),while the serum ZO-1 level in the CSVD group was lower(P<0.05).Compared with the normal function group,the levels of serum TG,LRG1 and HDAC3 in the functional impairment group were higher(P<0.05),and serum ZO-1 level in the functional impairment group was lower(P<0.05).The results of multivariate Logistic regression analysis showed that elevated ser-um levels of LRG1 and HDAC3 were independent risk factors for CI in CSVD patients(P<0.05),while ele-vated serum level of ZO-1 was an independent protective factor for CI in CSVD patients(P<0.05).ROC curve analysis results showed that the area under the curve(AUC)for serum LRG1,HDAC3 and ZO-1 indi-vidually diagnosing CI in CSVD patients were 0.818,0.808 and 0.827,respectively,while the AUC for their combined diagnosis was 0.943,which was superior to the AUCs of the individual indicators(ZLRG-joint=2.779,ZHDAC3-joint=3.068,ZZO-1-joint=2.480,all P<0.05).Conclusion In CSVD patients,serum levels of LRG1 and HDAC3 are elevated,while serum level of ZO-1 is decreased.The above three factors are all influencing factor for the occurrence of CI in CSVD patients,and their combined detection has high diagnostic value for CI.

丁帅;王梅蕾;吴真伟;唐春芳;余贤

江苏省无锡市锡山人民医院:急诊科,江苏 无锡 214105江苏省无锡市锡山人民医院:神经内科,江苏 无锡 214105江苏省无锡市锡山人民医院:急诊科,江苏 无锡 214105江苏省无锡市锡山人民医院:急诊科,江苏 无锡 214105江苏省无锡市锡山人民医院:急诊科,江苏 无锡 214105

医药卫生

脑小血管病认知功能障碍富亮氨酸α-2糖蛋白-1组蛋白去乙酰化酶3闭锁小带蛋白1诊断价值

cerebral small vessel diseasecognitive impairmentleucine rich alpha-2 glycoprotein-1histone deacetylase 3zonula occluden-1diagnostic value

《检验医学与临床》 2026 (2)

177-182,190,7

江苏省无锡市卫生健康委员会科研项目(Q202136).

10.3969/j.issn.1672-9455.2026.02.006

评论